BDMD (Baird Medical Investment Holdings) Net Cash per Share : $-0.63 (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Baird Medical Investment Holdings's Net Cash per Share for the quarter that ended in Jun. 2024 was $-0.63.

The historical rank and industry rank for Baird Medical Investment Holdings's Net Cash per Share or its related term are showing as below:

BDMD's Price-to-Net-Cash is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 8.35
* Ranked among companies with meaningful Price-to-Net-Cash only.

Baird Medical Investment Holdings Net Cash per Share Historical Data

The historical data trend for Baird Medical Investment Holdings's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Net Cash per Share Chart

Baird Medical Investment Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Net Cash per Share

-0.19

-0.42

-0.55

Baird Medical Investment Holdings Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
Net Cash per Share	-0.19	-0.42	-	-0.55	-0.63

Competitive Comparison of Baird Medical Investment Holdings's Net Cash per Share

For the Medical Devices subindustry, Baird Medical Investment Holdings's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baird Medical Investment Holdings's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's Price-to-Net-Cash falls into.

Baird Medical Investment Holdings Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Baird Medical Investment Holdings's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

	Net Cash per Share (A: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.51	-	21.001	-	-0.043)	/	35.450
=	-0.55

Baird Medical Investment Holdings's Net Cash per Share for the quarter that ended in Jun. 2024 is calculated as

	Net Cash per Share (Q: Jun. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.502	-	23.75	-	0.001)	/	35.4502
=	-0.63

Baird Medical Investment Holdings (NAS:BDMD) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Baird Medical Investment Holdings Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN

Website

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.